FR2393579B1 - - Google Patents

Info

Publication number
FR2393579B1
FR2393579B1 FR7816958A FR7816958A FR2393579B1 FR 2393579 B1 FR2393579 B1 FR 2393579B1 FR 7816958 A FR7816958 A FR 7816958A FR 7816958 A FR7816958 A FR 7816958A FR 2393579 B1 FR2393579 B1 FR 2393579B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7816958A
Other versions
FR2393579A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Publication of FR2393579A1 publication Critical patent/FR2393579A1/fr
Application granted granted Critical
Publication of FR2393579B1 publication Critical patent/FR2393579B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR787816958A 1977-06-06 1978-05-31 Agent antiviral et son application au traitement des affections virales Granted FR2393579A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6573977A JPS542336A (en) 1977-06-06 1977-06-06 Preventive and remedy for viral diseases

Publications (2)

Publication Number Publication Date
FR2393579A1 FR2393579A1 (fr) 1979-01-05
FR2393579B1 true FR2393579B1 (fr) 1980-06-13

Family

ID=13295678

Family Applications (1)

Application Number Title Priority Date Filing Date
FR787816958A Granted FR2393579A1 (fr) 1977-06-06 1978-05-31 Agent antiviral et son application au traitement des affections virales

Country Status (6)

Country Link
US (1) US4216226A (fr)
JP (1) JPS542336A (fr)
CA (1) CA1098827A (fr)
DE (1) DE2823346C2 (fr)
FR (1) FR2393579A1 (fr)
GB (1) GB1599612A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203967A (en) * 1977-01-13 1980-05-20 Hoffmann-La Roche Inc. Diagnostic test for malabsorption
IT1166905B (it) * 1978-09-23 1987-05-06 Hokuriku Pharmaceutical Agente emostatico e in grado di accrescere il numero delle piastrine, contenente acido alfa, beta-diamminopropionico e suoi derivati
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPH0629188B2 (ja) * 1987-10-22 1994-04-20 明治製菓株式会社 抗癌剤および復帰突然変異細胞取得剤
DE19843222A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen
EP1281767A3 (fr) * 2001-07-31 2003-05-28 Aladar A. Szalay Microbes et cellules lumineuses pour le diagnostic et le traitement des tumeurs
CN100562570C (zh) * 2003-06-18 2009-11-25 吉恩勒克斯公司 修饰的重组痘苗病毒及其它微生物,及其应用
WO2008100292A2 (fr) 2006-10-16 2008-08-21 Genelux Corporation Souches du virus de la vaccine modifié pour une utilisation dans des procédés diagnostiques et thérapeutiques
US20090117034A1 (en) * 2007-06-15 2009-05-07 Nanhai Chen Microorganisms for imaging and/or treatment of tumors
CA2836299A1 (fr) 2011-04-15 2012-10-18 Genelux Corporation Souches clonales de virus attenues de la vaccine et leurs procedes d'utilisation

Also Published As

Publication number Publication date
CA1098827A (fr) 1981-04-07
GB1599612A (en) 1981-10-07
US4216226A (en) 1980-08-05
FR2393579A1 (fr) 1979-01-05
DE2823346C2 (de) 1985-04-11
JPS542336A (en) 1979-01-09
DE2823346A1 (de) 1978-12-14

Similar Documents

Publication Publication Date Title
DE2812872C2 (fr)
DE2849998C2 (fr)
DE2752688C3 (fr)
DE2740044C2 (fr)
FR2393579B1 (fr)
FR2377334B3 (fr)
DE2816015C2 (fr)
DE2757967C3 (fr)
DE2812629C2 (fr)
FR2377493B1 (fr)
FR2376925B3 (fr)
DE2740130C2 (fr)
FR2377182B1 (fr)
DE2715995C2 (fr)
DE2753741C2 (fr)
DE2831230C2 (fr)
FR2347369B1 (fr)
BG25852A1 (fr)
CH604286A5 (fr)
BG25820A1 (fr)
BG25860A1 (fr)
BG26443A1 (fr)
BG25855A1 (fr)
BG25853A1 (fr)
BG26109A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse